tebu-bio is a European company specialised in providing innovative reagents and laboratory services in Life Sciences
X

Need an answer now?

Give us a call

Leave a message, we'll get back to you





Get advice about Time Bioscience

Time Bioscience

Time Bioscience - tebu-bio

Time Bioscience manufacture in vitro assay tools focusing on the Wnt/beta-catenin cell signaling pathway for drug discovery. Time Bioscience's focus lays on highly active proteins involved in this pathway like Wnt variants, Wnt signaling inhibitors, and Wnt signaling receptors, as well as reporter cell lines and their control cell lines.
 



Find your Time Bioscience products below or contact your tebu-bio local office.

Split per category

Cells, Media & Fractions

Cell Lines

Proteins & Peptides

Proteins

41 blog articles

4 webpages

41 blog articles


Complete tool box to facilitate Immunotherapy research | tebu-bio's blog Facebook LinkedIn Twitter YouTube

A new publication by BenMohamed F. et al. investigating the role of TLR9 in pulmonary infections | tebu-bio's blog Facebook LinkedIn Twitter YouTube

3 novel PD-L1 post-translational modifications identified | tebu-bio's blog Facebook LinkedIn Twitter YouTube

New - Continued use immunotherapy cell line expressing recombinant PD-1 | tebu-bio's blog Facebook LinkedIn Twitter YouTube

Three new pseudoviruses for SARS-CoV-2 studies | tebu-bio's blog Facebook LinkedIn Twitter YouTube

10 Human Immune Checkpoint biomarkers quantified simultaneously | tebu-bio's blog Facebook LinkedIn Twitter YouTube

New Reporter cell lines for Drug discovery and Immunotherapy checkpoint research | tebu-bio's blog Facebook LinkedIn Twitter YouTube

IDO/TDO enzymatic pathway as an additional target for Cancer Drug Discovery | tebu-bio's blog Facebook LinkedIn Twitter YouTube

How to improve your reporter gene assays? | tebu-bio's blog Facebook LinkedIn Twitter YouTube

PROTACs: A promising strategy in Drug Development | tebu-bio's blog Facebook LinkedIn Twitter YouTube

Versatile method to detect luciferase in reporter cell lines | tebu-bio's blog Facebook LinkedIn Twitter YouTube

Hyalose Select-Hyaluronic AcidTM products now available now from tebu-bio | tebu-bio's blog Facebook LinkedIn Twitter YouTube

Cell-based assay to discover new immuno-oncology treatments | tebu-bio's blog Facebook LinkedIn Twitter YouTube

Proteins with the High Purity (HiPTM) label make the difference | tebu-bio's blog Facebook LinkedIn Twitter YouTube

Human and Viral proteases as targets for SARS-CoV-2 treatment? | tebu-bio's blog Facebook LinkedIn Twitter YouTube

High efficiency transfection reagents for nucleic acid delivery | tebu-bio's blog Facebook LinkedIn Twitter YouTube

CAR T-Cell therapy: new hope for Immunotherapy and Cancer treatment | tebu-bio's blog Facebook LinkedIn Twitter YouTube

Immunotherapy research: How to easily build your own reporter cell line? | tebu-bio's blog Facebook LinkedIn Twitter YouTube

ELISA test to confirm elimination of Host Cell Proteins (HCP) from bioproductions | tebu-bio's blog Facebook LinkedIn Twitter YouTube

A focus on ATX-LPA signaling research tools | tebu-bio's blog Facebook LinkedIn Twitter YouTube

Six new reporter cellular lines for Immune checkpoint drug discovery | tebu-bio's blog Facebook LinkedIn Twitter YouTube

Immuno-Oncology: 6 must-haves to boost your R&D projects | tebu-bio's blog Facebook LinkedIn Twitter YouTube

New FcGR2B cell line: Boost your Immunotherapeutic antibody development | tebu-bio's blog Facebook LinkedIn Twitter YouTube

tebu-bio's blog | Acting and reacting in life sciences and biotechnologies - Part 39 Facebook LinkedIn Twitter YouTube

tebu-bio's blog | Acting and reacting in life sciences and biotechnologies - Part 41 Facebook LinkedIn Twitter YouTube

8 new JARID1 - JMJD2 HMT assays | tebu-bio's blog Facebook LinkedIn Twitter YouTube

Cell-based assay to discover new immuno-oncology treatments | tebu-bio's blog Facebook LinkedIn Twitter YouTube

IL-17A pathway - a key target for immunotherapies | tebu-bio's blog Facebook LinkedIn Twitter YouTube

tebu-bio's blog | Acting and reacting in life sciences and biotechnologies - Part 40 Facebook LinkedIn Twitter YouTube

How to choose the best ELISA for your project | tebu-bio's blog Facebook LinkedIn Twitter YouTube

5 key criteria for selecting the most appropriate ELISA kit to detect Human Cardiotrophin-1 | tebu-bio's blog Facebook LinkedIn Twitter YouTube

tebu-bio's blog | Acting and reacting in life sciences and biotechnologies - Part 21 Facebook LinkedIn Twitter YouTube

Prevent adapter dimer formation during NGS library prep | tebu-bio's blog Facebook LinkedIn Twitter YouTube

Immunotherapy Screening - B7-1 / CD28 and B7-1 / CTLA4 Pathways in Drug Discovery | tebu-bio's blog Facebook LinkedIn Twitter YouTube

H3K4me3 Histone Demethylase Fbxl10 Activity Assay | tebu-bio's blog Facebook LinkedIn Twitter YouTube

Measure Antibody-Dependent Cell-mediated Cytotoxicity (ADCC) | tebu-bio's blog Facebook LinkedIn Twitter YouTube

Screen for inhibitors of PD-1 signalling with a complete cellular assay system | tebu-bio's blog Facebook LinkedIn Twitter YouTube

Immunotherapy Screening - IDO pathway | tebu-bio's blog Facebook LinkedIn Twitter YouTube

SARS-CoV:ACE2 inhibitor small molecule screening assays | tebu-bio's blog Facebook LinkedIn Twitter YouTube

Immunotherapy Screening - A focus on PD-1/PD-L1/PD-L2 Pathway in drug discovery | tebu-bio's blog Facebook LinkedIn Twitter YouTube

How to easily screen adenosine A2AR agonists and antagonists? | tebu-bio's blog Facebook LinkedIn Twitter YouTube

4 Webpages